Intraoperative Conversion During Video-assisted Thoracoscopy Resection for Lung Cancer Does Not Alter Survival (ICVATR)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04663191 |
Recruitment Status :
Completed
First Posted : December 10, 2020
Last Update Posted : December 16, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Anatomical resection with systematic lymph-node dissection is currently the standard of care for the treatment of early stage non-small cell lung cancer. The use of minimally invasive approaches has increased greatly over the last two decades [either video-assisted thoracoscopic surgery (VATS) or robotic-assisted thoracoscopic surgery (RATS)], as they provide the patient with better outcomes than open thoracotomy. Minimally invasive VATS lobectomy for a standard case is generally a straightforward procedure for a well-trained surgical team, although concomitant preoperative pathologies or intraoperative findings/adverse events may result in technical difficulties, leading to intraoperative conversion, commonly by thoracotomy.
The investigators aimed to assess long-term outcomes in a consecutive cohort of patients treated by anatomical pulmonary resection either using VATS, VATS requiring intraoperative conversion to thoracotomy, or upfront open thoracotomy for lung-cancer surgery.
Condition or disease | Intervention/treatment |
---|---|
Video-assisted Thoracoscopic Surgery Lung Cancer Lobectomy Survival Surgery | Procedure: anatomical resection |
Study Type : | Observational |
Actual Enrollment : | 843 participants |
Observational Model: | Case-Control |
Time Perspective: | Retrospective |
Official Title: | Intraoperative Conversion During Video-assisted Thoracoscopy Resection for Lung Cancer Does Not Alter Survival |
Actual Study Start Date : | January 2, 2020 |
Actual Primary Completion Date : | December 2, 2020 |
Actual Study Completion Date : | December 3, 2020 |

Group/Cohort | Intervention/treatment |
---|---|
Full VATS |
Procedure: anatomical resection
Anatomical resection with systematic lymph-node dissection |
VATS with conversion |
Procedure: anatomical resection
Anatomical resection with systematic lymph-node dissection |
Thoracotomy upfront |
Procedure: anatomical resection
Anatomical resection with systematic lymph-node dissection |
- Overall survival during the follow-up period after surgery [ Time Frame: from day of surgery up to 7 years ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- All consecutive patients treated by anatomical lobar pulmonary resection (lobectomy, bilobectomy) or anatomical sublobar pulmonary resection (segmentectomy) for non-small cell lung cancer (NSCLC), either by VATS (eventually with intraoperative conversion) or upfront thoracotomy.
Exclusion Criteria:
- patients with non-anatomical pulmonary resection (wedge resection)
- patients with a histology other than NSCLC (benign or metastatic from another primitive cancer), stage IV NSCLC disease,
- patients with multiple primary NSCLC (synchronous or metachronous)
- patients with incomplete resection (R+)
- patient for whom a VATS approach was never considered

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04663191
France | |
CHU Amiens | |
Amiens, France, 80480 |
Responsible Party: | Centre Hospitalier Universitaire, Amiens |
ClinicalTrials.gov Identifier: | NCT04663191 |
Other Study ID Numbers: |
T38 |
First Posted: | December 10, 2020 Key Record Dates |
Last Update Posted: | December 16, 2020 |
Last Verified: | December 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
video-assisted thoracoscopic surgery lung-cancer surgery intraoperative conversion to open surgery lobectomy survival |
Lung Neoplasms Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms by Site |
Neoplasms Lung Diseases Respiratory Tract Diseases |